Menu
Email page PDF view Print view Email Alert Social Media Sharing

SEC Filings

 

Other Filings
Filing Description Filing Type Filing Date Event Date  
10-Q
10-Q 7/31/2019 6/30/2019
Transcript
CPT 11/8/2019
Abstract: Transcript of TCF Financial Corp at BancAnalysts Association of Boston Conference on 11/8/2019
Transcript
CPT 11/5/2019
Abstract: Transcript of TCF Financial Corp at Bank of America Merrill Lynch Future of Financials Conference on 11/5/2019
Registration Statement
8-A12B 7/30/2019
Abstract: Registrant filed a description of its depositary shares in order to register them under the Securities Exchange Act of 1934.
13-F
13F-NT 7/25/2019 6/30/2019
13-F
13F-HR 7/25/2019 6/30/2019
8-K
8-K 7/24/2019 7/24/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K
8-K 7/24/2019 7/24/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K
8-K 7/16/2019 7/16/2019
Abstract: On July 16, registrant and TCF Financial Corp. announced the receipt of regulatory approval from the Board of Governors of the Federal Reserve System to complete the proposed merger of equals in which TCF Financial will merge into the registrant.
11-K
11-K 6/27/2019 12/31/2018
Abstract: Registrant filed the annual report for its 401(k) savings plan.
8-K
8-K 6/25/2019 6/25/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 6/21/2019 6/21/2019
Abstract: Registrant reported that the Office of the Comptroller of the Currency has issued its approval of the merger of TCF National Bank and Chemical Bank.
8-K
8-K 6/7/2019 6/7/2019
Abstract: On June 7, registrant and TCF Financial Corp. announced that at separate special meetings, each company’s shareholders approved the proposed merger of equals in which TCF Financial will merge into the registrant.
8-K
8-K 6/6/2019 6/6/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Financial Statements and Exhibits.
Registration Statement
S-8 5/15/2019
Abstract: Registrant filed a registration statement for up to 2.4 million shares of common stock in an offering valued at approximately $99 million offered through its stock incentive plan of 2019.
8-K
8-K 5/8/2019 5/8/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Submission of Matters to a Vote of Security Holder.
10-Q
10-Q 5/8/2019 3/31/2019
13-F
13F-NT 5/6/2019 3/31/2019
13-F
13F-HR 5/6/2019 3/31/2019
8-K
8-K 5/3/2019 5/3/2019
Abstract: On May 2, registrant and TCF Financial Corp. announced that each company will hold its special meeting of shareholders on June 7 for the companies’ respective shareholders to consider and vote on the proposals related to the definitive merger agreement in which TCF Financial and the registrant will combine in an all-stock merger of equals transaction.
Prospectus
424B3 5/3/2019
Prospectus
425 5/3/2019
Registration Statement
S-4/A 5/2/2019
Abstract: Registrant filed amendment No. 1 to its registration statement to file additional information in connection with its offer for 85,232,387 shares of common stock in an offering valued at approximately $3.29 billion, for 7,000 shares of 5.70% series C non-cumulative perpetual preferred stock in an offering valued at $175 million and for an unspecified amount of depositary shares, each representing a 0.001 interest in a share of 5.70% series C non-cumulative perpetual preferred stock in connection with its proposed acquisition of TCF Financial Corp.
Prospectus
425 4/25/2019
8-K
8-K 4/23/2019 4/23/2019
Abstract: On April 23, registrant reported its net income for the quarter ended March 31. Registrant declared a dividend of 34 cents per share, payable on June 21 to shareholders as of June 7. The presentation was included by exhibit.
Prospectus
425 4/23/2019
8-K
8-K 4/10/2019 4/10/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
Registration Statement
S-4 3/29/2019
Abstract: Registrant filed a registration statement for 85,232,387 shares of common stock in an offering valued at approximately $3.29 billion, for 7,000 shares of 5.70% series C non-cumulative perpetual preferred stock in an offering valued at $175 million and for an unspecified amount of depositary shares, each representing a 0.001 interest in a share of 5.70% series C non-cumulative perpetual preferred stock in connection with its proposed acquisition of TCF Financial Corp.
Proxy
DEF 14A 3/28/2019 5/7/2019
Proxy
DEFA14A 3/28/2019
Merger App
Y-3 3/21/2019 3/15/2019
Abstract: Registrant filed an application with the FRB to seek approval to acquire TCF Financial Corporation. The agreement and plan of merger was included with the filing.
Prospectus
425 3/19/2019
Prospectus
425 3/13/2019
Prospectus
425 3/1/2019
Prospectus
425 3/1/2019
10-K
10-K 2/28/2019 12/31/2018
Prospectus
425 2/20/2019
Prospectus
425 2/20/2019
13-D
SC 13G/A 2/11/2019
13-F
13F-HR 2/7/2019 12/31/2018
13-F
13F-NT 2/7/2019 12/31/2018
8-K
8-K 1/28/2019 1/28/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Entry into a Material Definitive Agreement; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; and Financial Statements and Exhibits.
8-K
8-K 1/28/2019 1/28/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K
8-K 1/28/2019 1/28/2019
Abstract: On Jan. 28, registrant and TCF Financial Corp. announced the signing of a definitive agreement to combine in an all-stock merger of equals transaction. The slideshow presentation was included by exhibit.
Prospectus
425 1/28/2019
Prospectus
425 1/28/2019
Prospectus
425 1/28/2019
Prospectus
425 1/28/2019
13-D
SC 13G/A 1/24/2019
8-K
8-K 1/22/2019 1/22/2019
Abstract: On Jan. 22, registrant declared a dividend of 34 cents per share, payable March 15 to shareholders as of March 1.
8-K
8-K 1/11/2019 1/11/2019
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
Annual Report
AR 12/31/2018
10-Q
10-Q 11/8/2018 9/30/2018
8-K
8-K 11/6/2018 11/6/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
13-F
13F-NT 11/6/2018 9/30/2018
13-F
13F-HR 11/6/2018 9/30/2018
8-K
8-K 10/23/2018 10/23/2018
Abstract: On Oct. 23, registrant reported its net income for the quarter ended Sept. 30. Registrant declared a dividend of 34 cents per share, payable Dec. 21 to shareholders as of Dec. 7. The earnings presentation slides were included by exhibit.
8-K
8-K 10/9/2018 10/9/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 9/5/2018 9/5/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
13-F
13F-HR 8/9/2018 6/30/2018
13-F
13F-NT 8/9/2018 6/30/2018
10-Q
10-Q 8/8/2018 6/30/2018
8-K
8-K 7/25/2018 7/25/2018
Abstract: On July 25, registrant announced that its board of directors approved the relocation of the principal executive offices of the registrant and the main branch of Chemical Bank to its offices in Detroit from its offices in Midland.
8-K
8-K 7/24/2018 7/24/2018
Abstract: On July 24, registrant reported its net income for the quarter ended June 30. Registrant declared a third-quarter of 2018 dividend of 34 cents per share, payable Sept. 21 to shareholders as of Sept. 7. The earnings presentation slides were included by exhibit.
8-K
8-K 7/11/2018 7/11/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Financial Statements and Exhibits.
8-K
8-K 7/10/2018 7/10/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 7/3/2018 7/3/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
11-K
11-K 6/28/2018 12/31/2017
Abstract: Registrant filed the annual report for its 401(k) savings plan.
13-F
13F-NT 5/11/2018 3/31/2018
13-F
13F-HR 5/11/2018 3/31/2018
8-K
8-K 5/9/2018 5/9/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q
10-Q 5/9/2018 3/31/2018
8-K
8-K 4/30/2018 4/30/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Submission of Matters to a Vote of Security Holder.
8-K
8-K 4/24/2018 4/24/2018
Abstract: On April 24, registrant reported its net income for the quarter ended March 31. Registrant declared a quarterly dividend of 28 cents per share, payable June 15 to shareholders as of June 1. The earnings presentation slides were included by exhibit.
8-K
8-K 4/10/2018 4/10/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
Regulatory Filing: Depository
Y-6 3/31/2018 12/31/2017
Proxy
DEF 14A 3/16/2018 4/25/2018
Proxy
DEFA14A 3/16/2018
10-K
10-K 2/28/2018 12/31/2017
13-F
13F-HR 2/22/2018 12/31/2017
13-F
13F-NT 2/13/2018 12/31/2017
13-D
SC 13G/A 2/9/2018
8-K
8-K 2/8/2018 2/8/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 1/26/2018 1/26/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year and Financial Statements and Exhibits.
8-K
8-K 1/23/2018 1/23/2018
Abstract: On Jan. 23, registrant reported its net income for the quarter and for the year ended Dec. 31, 2017. Registrant declared a first-quarter 2018 dividend of 28 cents per share on its common stock, payable March 16 to shareholders as of March 2. The earnings presentation was included by exhibit.
13-D
SC 13G/A 1/19/2018
8-K
8-K 1/9/2018 1/9/2018
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
Annual Report
AR 12/31/2017
8-K
8-K 12/29/2017 12/29/2017
Abstract: Registrant reported that on Dec. 22, H.R.1, known as the Tax Cuts and Jobs Act, was signed into law, which among other items, reduces the corporate income tax rate to 21%, effective Jan. 1, 2018. Registrant reported that it is completing a revaluation of the registrant's net deferred tax assets.
13-F
13F-HR 11/14/2017 9/30/2017
13-F
13F-NT 11/14/2017 9/30/2017
8-K
8-K 11/13/2017 11/13/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q
10-Q 11/8/2017 9/30/2017
8-K
8-K 10/24/2017 10/24/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K
8-K 10/12/2017 10/12/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 9/19/2017 9/19/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 9/12/2017 9/12/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Costs Associated with Exit or Disposal Activities and Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
13-F
13F-HR 8/10/2017 6/30/2017
13-F
13F-NT 8/10/2017 6/30/2017
10-Q
10-Q 8/9/2017 6/30/2017
8-K
8-K 8/8/2017 8/8/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 7/25/2017 7/25/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K
8-K 7/19/2017 7/19/2017
Abstract: On July 18, registrant declared a dividend of 28 cents per share, payable Sept. 15 to shareholders as of Sept. 1.
8-K
8-K 7/13/2017 7/13/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
11-K
11-K 6/27/2017 12/31/2016
Abstract: Registrant filed the annual report for its 401(k) savings plan.
8-K
8-K 6/23/2017 6/23/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K
8-K 6/21/2017 6/21/2017
Abstract: On June 21, registrant announced that David Ramaker decided to retire as its director, CEO and president in the third quarter of this year. Registrant announced that Thomas Shafer was named vice chairman of the registrant and joins the boards of directors of the registrant and Chemical Bank. Registrant also announced that Shafer was also named president and CEO of Chemical Bank.
13-F
13F-HR 5/15/2017 3/31/2017
13-F
13F-NT 5/15/2017 3/31/2017
10-Q
10-Q 5/10/2017 3/31/2017
Registration Statement
S-3ASR 5/10/2017
Abstract: Registrant filed a registration statement for an unspecified amount of certain types of securities. Proceeds from the offering will be used for general corporate purposes.
Registration Statement
S-8 5/10/2017
Abstract: Registrant filed a registration statement for up to 1,750,000 shares of common stock in an offering valued at approximately $86.2 million offered through its stock incentive plan of 2017.
Registration Statement
S-8 5/10/2017
Abstract: Registrant filed a registration statement for up to 300,000 shares of common stock in an offering valued at approximately $14.8 million offered through its 401(k) savings plan.
8-K
8-K 5/9/2017 5/9/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K
8-K 4/28/2017 4/28/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Submission of Matters to a Vote of Security Holder.
8-K
8-K 4/25/2017 4/25/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K
8-K 4/20/2017 4/20/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure.
8-K
8-K 4/17/2017 4/17/2017
Abstract: 8-K filed by Chemical Financial Corp. (CHFC) covering Regulation FD Disclosure and Financial Statements and Exhibits.
13-D
SC 13G/A 4/10/2017
Regulatory Filing: Depository
Y-6 3/31/2017 12/31/2016
Transcript
AST 3/14/2017
Abstract: Transcript of Chemical Financial Corp Investor Day on 3/14/2017
8-K
8-K 3/13/2017 3/13/2017
Abstract: Registrant furnished the investor presentation materials which were to be used by its management in a meeting with the investors and equity research analyst at an investor day event.
Proxy
DEF 14A 3/10/2017 4/26/2017
Proxy
DEFA14A 3/10/2017
10-K
10-K 3/1/2017 12/31/2016
Proxy
PRE 14A 2/21/2017 2/21/2017
13-F
13F-NT 2/13/2017 12/31/2016
13-F
13F-HR 2/13/2017 12/31/2016
13-D
SC 13G/A 2/10/2017
8-K
8-K 2/9/2017 2/9/2017
Abstract: Registrant furnished the investor presentation materials which are to be used by its management in meetings with investors at the Keefe, Bruyette & Woods Financial Services Symposium beginning Feb. 9.
13-D
SC 13G/A 2/9/2017
8-K
8-K 1/25/2017 1/25/2017
Abstract: On Jan. 25, registrant reported its net income for the quarter and its net income for the year ended Dec. 31, 2016. The presentation was included by exhibit.
8-K
8-K 1/23/2017 1/17/2017
Abstract: On Jan. 23, registrant announced that Jeffrey Tate, corporate auditor for The Dow Chemical Co., was appointed to the board of directors of the registrant, effective March 1.
13-D
SC 13G/A 1/23/2017
8-K
8-K 1/17/2017 1/17/2017
Abstract: On Jan. 17, registrant announced the release date of its fourth-quarter and full-year 2016 results.
Annual Report
AR 12/31/2016
8-K
8-K 11/17/2016 11/17/2016
Abstract: Registrant reported that on Nov. 17, it is making a presentation to analysts and investors. The presentation was included by exhibit.
8-K
8-K 11/14/2016 11/14/2016
Abstract: Registrant reported that it completed the consolidation of Talmer Bank and Trust with and into Chemical Bank, as of the close of business on Nov. 10.
13-F
13F-HR 11/10/2016 9/30/2016
10-Q
10-Q 11/9/2016 9/30/2016
8-K
8-K 10/25/2016 10/25/2016
Abstract: On Oct. 25, registrant reported its net income for the quarter ended Sept. 30. The presentation slides were included by exhibit.
8-K
8-K 10/17/2016 10/17/2016
Abstract: On Oct. 17, registrant announced the release date of its third-quarter financial results.
8-K
8-K/A 9/20/2016 8/31/2016
Abstract: Registrant amended its Form 8-K to file financial information, including pro formas, in connection with the merger of Talmer Bancorp Inc. with and into the registrant.
8-K
8-K 9/7/2016 9/7/2016
Abstract: Registrant reported that on Sept. 7, it will make a presentation to analysts and investors. The slideshow presentation was included by exhibit.
Registration Statement
S-8 POS 9/1/2016
8-K
8-K 8/31/2016 8/31/2016
Abstract: On Aug. 31, registrant announced that it completed merger with Talmer Bancorp Inc. The employment agreement, among other things, was included by exhibit.
13-F
13F-HR 8/15/2016 6/30/2016
8-K
8-K 8/10/2016 8/8/2016
Abstract: On Aug. 10, registrant announced that it received regulatory approvals of the merger between registrant and Talmer Bancorp Inc. from the State of Michigan Department of Insurance and Financial Services and the board of governors of the Federal Reserve System.
Merger Approval: Bank
MA Approval 8/8/2016 8/8/2016
Abstract: On August 8, the FRB issued an order approving the merger of Bank Holding Companies, the merger of banks, and the establishment of branches.
8-K
8-K 8/2/2016 8/2/2016
Abstract: Registrant reported that on Aug. 2, it is making a presentation to analysts and investors. The presentation was included by exhibit.
10-Q
10-Q 7/28/2016 6/30/2016
8-K
8-K 7/26/2016 7/26/2016
Abstract: On July 26, registrant reported its net income for the quarter ended June 30. The presentation was included by exhibit.
8-K
8-K 7/20/2016 7/20/2016
Abstract: On July 20, registrant announced the release date of its second-quarter 2016 results.
8-K
8-K 7/20/2016 7/19/2016
Abstract: Registrant reported the results of its special meeting of shareholders held July 19.
8-K
8-K 7/13/2016 7/13/2016
Abstract: Registrant reported that it will hold a special meeting of shareholders on July 19.
Prospectus
425 7/13/2016
8-K
8-K 7/7/2016 7/7/2016
Abstract: Registrant provided information regarding the supplement to the joint proxy statement and prospectus.
Prospectus
425 7/7/2016
Prospectus
425 7/7/2016
11-K
11-K 6/21/2016 12/31/2015
Abstract: Registrant filed the annual report for its 401(k) savings plan.
Prospectus
424B3 6/13/2016
Registration Statement
S-4/A 6/9/2016
Abstract: Registrant filed amendment No. 3 to its registration statement to file additional information in connection with its offer for up to 35,094,409 shares of common stock in connection with its proposed acquisition of Talmer Bancorp Inc.
Registration Statement
S-4/A 6/2/2016
Abstract: Registrant filed amendment No. 2 to its registration statement to file additional information in connection with its offer for up to 35,094,409 shares of common stock in connection with its proposed acquisition of Talmer Bancorp Inc.
8-K
8-K 5/31/2016 5/31/2016
Abstract: Registrant provided information regarding the agreement and plan of merger between the registrant and Talmer Bancorp Inc. Registrant provided the updated information regarding the executive leadership team of Chemical Bank that consists of David Ramaker and certain others.
Prospectus
425 5/31/2016
Registration Statement
S-4/A 5/17/2016
Abstract: Registrant filed amendment No. 1 to its registration statement to file additional information in connection with its offer for up to 35,094,409 shares of common stock in connection with its proposed acquisition of Talmer Bancorp Inc.
13-F
13F-HR 5/5/2016 3/31/2016
10-Q
10-Q 4/27/2016 3/31/2016
8-K
8-K 4/19/2016 4/18/2016
Abstract: Registrant reported the results of its annual meeting of shareholders held April 18.
Prospectus
425 4/19/2016
8-K
8-K 4/15/2016 4/15/2016
Abstract: On April 15, registrant reported its net income for the quarter ended March 31. The presentation slides were included by exhibit.
Prospectus
425 4/15/2016
8-K
8-K 4/12/2016 4/12/2016
Abstract: Registrant reported that it will hold its annual meeting of shareholders on April 18.
8-K
8-K 4/11/2016 4/11/2016
Abstract: On April 11, registrant announced the release date of its first-quarter results.
Merger App
Y-3 4/7/2016 4/7/2016
Abstract: Registrant filed an application with the FRB to seek approval to acquire Talmer Bancorp, Inc. The agreement and plan of merger was included with the filing.
Regulatory Filing: Depository
Y-6 3/31/2016 12/31/2015
Registration Statement
S-4 3/31/2016
Abstract: Registrant filed a registration statement for 35,094,409 shares of common stock in an offering valued at approximately $1.21 billion in connection with its proposed acquisition of Talmer Bancorp Inc.
Proxy
DEF 14A 3/4/2016 4/18/2016
Proxy
DEFA14A 3/4/2016
Proxy
DEFA14A 3/4/2016
Prospectus
425 3/4/2016
10-K
10-K 2/26/2016 12/31/2015
13-F
13F-HR 2/12/2016 12/31/2015
8-K
8-K 2/11/2016 2/11/2016
Abstract: Registrant reported that beginning Feb. 11, its senior management will begin meeting with certain analysts and institutional investors to discuss the merger of Talmer Bancorp Inc. with and into the registrant. The slide presentation was included by exhibit.
Prospectus
425 2/11/2016
13-D
SC 13G/A 2/11/2016
13-D
SC 13G/A 2/9/2016
13-D
SC 13G/A 2/4/2016
8-K
8-K 2/1/2016 2/1/2016
Abstract: Registrant reported that beginning Feb. 2, its senior management will begin meeting with certain analysts and institutional investors to discuss the agreement and plan of merger providing for the merger of the registrant with and into Chemical Financial Corp., and will provide the slide presentation. The presentation was included by exhibit.
Prospectus
425 2/1/2016
13-D
SC 13G 1/28/2016
Prospectus
425 1/27/2016
Prospectus
425 1/27/2016
8-K
8-K 1/26/2016 1/26/2016
Abstract: Registrant reported that on Jan. 26, it and Talmer Bancorp Inc. issued a joint press release announcing the execution of an agreement and plan of merger providing for the merger of Talmer Bancorp with and into the registrant. The presentation was included by exhibit.
8-K
8-K 1/26/2016 1/25/2016
Abstract: On Jan. 26, registrant and Talmer Bancorp Inc. announced the execution of a definitive agreement for the registrant to partner with Talmer Bancorp in a cash and common stock merger transaction valued at approximately $1.1 billion. The agreement and plan of merger, dated Jan. 25, was included by exhibit.
Prospectus
425 1/26/2016
Prospectus
425 1/26/2016
Prospectus
425 1/26/2016
8-K
8-K 1/25/2016 1/25/2016
Abstract: On Jan. 25, registrant reported its net income for the quarter and its net income for the year ended Dec. 31, 2015. The presentation was included by exhibit.
8-K
8-K 1/21/2016 1/20/2016
Abstract: On Jan. 20, registrant announced the release dates of its fourth-quarter and full-year 2015 results.
Annual Report
AR 12/31/2015
8-K
8-K 11/16/2015 11/13/2015
Abstract: Registrant reported that it completed the consolidation of its subsidiary banks, the Bank of Holland and the Bank of Northern Michigan, with and into Chemical Bank, as of the close of business on Nov. 13.
13-F
13F-HR 11/13/2015 9/30/2015
10-Q
10-Q 11/5/2015 9/30/2015
8-K
8-K 10/21/2015 10/21/2015
Abstract: On Oct. 21, registrant reported its net income for the quarter ended Sept. 30. The earnings presentation slides were included by exhibit.
8-K
8-K 10/16/2015 10/16/2015
Abstract: On Oct. 16, registrant announced the release date of its third-quarter 2015 results.
Registration Statement
POS AM 10/9/2015
8-K
8-K 9/22/2015 9/16/2015
Abstract: Registrant reported that Kenneth Johnson, executive vice president and director of bank operations of Chemical Bank, resigned from Chemical Bank, effective Sept. 16.
13-D
SC 13G/A 9/9/2015
13-F
13F-HR 8/10/2015 6/30/2015
10-Q
10-Q 8/5/2015 6/30/2015
Registration Statement
S-3DPOS 7/30/2015
8-K
8-K 7/21/2015 7/21/2015
Abstract: On July 21, registrant reported its net income for the quarter ended June 30. The presentation was included by exhibit.
8-K
8-K 7/16/2015 7/16/2015
Abstract: On July 16, registrant announced the release date of its second-quarter results.
11-K
11-K 6/18/2015 12/31/2014
Abstract: Registrant filed the annual report for its 401(k) savings plan.
Registration Statement
S-4MEF 6/2/2015
Registration Statement
S-8 POS 6/2/2015
8-K
8-K 6/1/2015 5/31/2015
Abstract: On June 1, registrant announced that effective May 31, it completed its acquisition of Lake Michigan Financial Corp. in a cash-and-stock transaction valued at approximately $187.4 million. Registrant also announced that Rich Lievense will join the registrant's board of directors, expanding the board to eight directors.
13-F
13F-HR 5/11/2015 3/31/2015
8-K
8-K 5/5/2015 5/4/2015
Abstract: Registrant reported that it and Lake Michigan Financial Corp. entered into an agreement and plan of merger between the registrant and Lake Michigan Financial, dated as of Jan. 5, pursuant to which Lake Michigan Financial will merge with and into the registrant.
10-Q
10-Q 4/30/2015 3/31/2015
Registration Statement
S-8 4/30/2015
Abstract: Registrant filed a registration statement for up to 1.3 million shares of common stock in an offering valued at approximately $41.2 million offered through its stock incentive plan of 2015.
Prospectus
425 4/23/2015
Prospectus
425 4/23/2015
8-K
8-K 4/21/2015 4/20/2015
Abstract: Registrant reported the results of its annual meeting of shareholders held April 20.
8-K
8-K 4/20/2015 4/20/2015
Abstract: On April 20, registrant and Chemical Bank announced a series of executive management and organizational structure changes, effective immediately, including the appointment of Thomas Kohn to be vice chairman and a member of the Chemical Bank board of directors.
8-K
8-K 4/20/2015 4/20/2015
Abstract: On April 20, registrant and Chemical Bank announced a series of executive management and organizational structure changes, effective immediately, including the appointment of Thomas Kohn to be vice chairman and a member of the Chemical Bank board of directors.
8-K
8-K 4/17/2015 4/17/2015
Abstract: On April 17, registrant reported its net income for the quarter ended March 31. The presentation was included by exhibit.
8-K
8-K 4/14/2015 4/14/2015
Abstract: On April 14, registrant announced the release date of its first-quarter 2015 results.
8-K
8-K 4/13/2015 4/13/2015
Abstract: Registrant reported that it will hold its annual meeting of shareholders on April 20.
8-K
8-K 4/8/2015 4/8/2015
Abstract: Registrant provided information regarding its solicitation of proxies with respect to various proposals to be acted upon at the annual meeting of stockholders.
Proxy
DEFA14A 4/8/2015
Prospectus
424B3 4/3/2015
8-K
8-K 4/1/2015 4/1/2015
Abstract: On April 1, registrant announced that it completed its acquisition of Monarch Community Bancorp Inc. in an all-stock transaction valued at approximately $27.2 million based on the registrant's closing stock price on March 31.
Regulatory Filing: Depository
Y-6 3/31/2015 12/31/2014
Proxy
DEF 14A 3/6/2015 4/20/2015
Proxy
DEFA14A 3/6/2015
Proxy
DEFA14A 3/6/2015
Prospectus
425 3/6/2015
Registration Statement
S-4 3/6/2015
Abstract: Registrant filed a registration statement for 4,324,573 shares of common stock in an offering valued at approximately $37.1 million in connection with its proposed merger with Lake Michigan Financial Corp.
10-K
10-K 2/27/2015 12/31/2014
8-K
8-K 2/25/2015 2/25/2015
Abstract: Registrant furnished investor presentation materials to be used by its management in meetings with investors at a conference sponsored by Keefe Bruyette & Woods Inc. beginning Feb. 25.

The information that is on or available through this site speaks only as of the particular date or dates of that information. We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information. TCF Financial Corporation does not undertake an obligation, and disclaims any duty, to update any of the information on or available through this site.